Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers Dabra and Pharos excimer laser products for the treatment of psoriasis and other skin conditions. It serves dermatologists, cardiologists, patients, health insurers with expert medical facilities. Ra Medical Systems markets its products through direct sales forces in the United States and Israel; and through distributors worldwide. The company was founded in 2002 and is headquartered in San Diego, California.

Catheter Precision

Catheter Precision (VTAK) Proxy Filing Summary | Quartr

Google Play

App Store

App links

Article Categories

Prefooter USP - CTA App

Dig deeper into the Visa Inc fundamentals on Quartr.

Features CTA

Product

Use cases

Discover

Resources

Company

email

Features

Platforms

Featured article

Pricing

Contact sales

Simple CTA

events-root

Catheter Precision Inc

Six proposals seek approval for share issuances, a reverse split, and governance flexibility.

Proxy Filing

Registering up to $20M in securities, with proceeds for operations and growth in cardiac EP tech.

Registration Filing

Registering 12.86M shares for resale by PIPE investors; proceeds only from warrant exercises.

Annual meeting to vote on director, share issuances, reverse split, and auditor ratification.

Annual meeting seeks approval for director, share issuances, reverse split, and auditor ratification.

Special Meeting seeks approval for key capital, equity, and governance proposals.

Special Meeting to vote on warrant exercises, share increase, equity plan, and auditor ratification.

Vote sought on major share authorization increase and auditor ratification to support future financing.

Virtual annual meeting to vote on director, share issuances, reverse split, and auditor.

### Executive summary
- Appointment of Philip Anderson as Chief Financial Officer, effective immediately, following a comprehensive search.
- Margrit Thomassen transitions from Interim CFO to Controller.
- Company operates in the cardiac electrophysiology market, with two products at the start of their revenue cycle and strong clinical evidence.

### Board of directors and corporate governance
- CEO David Jenkins highlights the management team's experience, including Marie-Claude Jacques, former VP at Boston Scientific.

### Executive compensation and say-on-pay
- Philip Anderson received an inducement award of options to purchase 500,000 shares at $0.53 per share, vesting monthly over three years, with a 10-year term.
- Options granted under NYSE American rules, not requiring shareholder approval.

Catheter Precision (VTAK) Proxy Filing summary

Proxy Filing summary

Executive summary

Board of directors and corporate governance

Executive compensation and say-on-pay

Latest events from Catheter Precision